fbpx

Test Yourself Against Global eSports Champions and Discover Eyezen Lenses

St.Laurent, QC – Essilor launched the Eyezen Challenge in association with Fnatic, one of the world’s top ranked eSports teams. This immersive digital experience will allow everyone to challenge one of the world stars of eSports, using just their eyes…

This challenge has been created to educate a generation of young Internet users, who can spend up to 7 hours a day on screens, about the importance of preserving their vision.

The experience features the Fnatic, one of the leading international teams in eSports, and incorporates some aspects of the League of Legends game. A gaze tracking technology allows the player to neutralize targets and harmful blue-violet lights that appear on the screen. During the Eyezen Challenge, the player will face global eSports star Martin Rekkles Larsson, equipped with Eyezen™ lenses, in a unique face-to-face encounter. Players who achieve the best scores will participate in a draw with the chance to see a live game of the Fnatic team.

Enjoy the experience on Eyezen-challenge.com

To read full press release, click HERE.

 

 

Featured Posts

SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read More
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read More
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read More
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read More
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more